BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17372305)

  • 21. Protein kinase A suppresses the differentiation of 3T3-L1 preadipocytes.
    Li F; Wang D; Zhou Y; Zhou B; Yang Y; Chen H; Song J
    Cell Res; 2008 Feb; 18(2):311-23. PubMed ID: 18195731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E; Calvo JC
    J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor.
    Nanjundan M; Sun J; Zhao J; Zhou Q; Sims PJ; Wiedmer T
    J Biol Chem; 2003 Sep; 278(39):37413-8. PubMed ID: 12871937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production.
    Cooper KL; Myers TA; Rosenberg M; Chavez M; Hudson LG
    Toxicol Appl Pharmacol; 2004 Nov; 200(3):177-85. PubMed ID: 15504454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
    Arany I; Faisal A; Nagamine Y; Safirstein RL
    J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells.
    Caverzasio J; Palmer G; Suzuki A; Bonjour JP
    J Bone Miner Res; 2000 Sep; 15(9):1697-706. PubMed ID: 10976990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
    Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
    Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts.
    Park CH; Chung JH
    J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ; Schiemann WP
    Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
    Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
    EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of orexin A on GLUT4 expression and lipid content via MAPK signaling in 3T3-L1 adipocytes.
    Shen Y; Zhao Y; Zheng D; Chang X; Ju S; Guo L
    J Steroid Biochem Mol Biol; 2013 Nov; 138():376-83. PubMed ID: 23907013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic M3 and epidermal growth factor receptors activate mutually inhibitory signaling cascades in human neuroblastoma SH-SY5Y cells.
    Zhang L; Jope RS
    Biochem Biophys Res Commun; 1999 Feb; 255(3):774-7. PubMed ID: 10049786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic stretch-induced cPLA2 mediates ERK 1/2 signaling in rabbit proximal tubule cells.
    Alexander LD; Alagarsamy S; Douglas JG
    Kidney Int; 2004 Feb; 65(2):551-63. PubMed ID: 14717925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for Grb2-associated binder-1 in growth hormone signaling.
    Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
    Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.